However, SUCLG2 expression has been found to be not significantly different between t-NEPC and high-grade adenocarcinoma patients [56], indicating that LIFR activation and STAT3 signaling are not exclusive regulators of SUCLG2 in t-NEPC. This evidence concerns the gene LIFR and adenocarcinoma.